CUPERTINO, CA / ACCESSWIRE / May 14, 2020 / Aemetis, Inc. AMTX, an advanced renewable fuels and biochemicals company, today announced its financial results for the three months ended March 31, 2020.
"During the first quarter of 2020, Aemetis continued to make steady progress despite significant challenges related to Covid 19 restrictions," said Eric McAfee, Chairman and CEO of Aemetis. "Progress continued on the carbon reduction and revenue expansion projects to drive significant revenue increases and positive earnings. In our dairy renewable natural gas project, we completed and tested the first two dairy digesters and began constructing the four mile pipeline to connect the two dairies to the Keyes ethanol plant; we completed the construction and began commercial operation of the carbon dioxide capture system at our Keyes plant to supply the newly-built Messer CO2 plant under a long term contract; and we made progress toward commencing construction of our below zero carbon content California waste wood ethanol biorefinery. Importantly, all of the EB-5 investors in our current offering were granted National Interest Expedite approval to process their applications at the USCIS in approximately 90 days instead of up to three years which has significantly increased the number of interested investors."
Today, Aemetis will host an earnings review call at 11:00 a.m. Pacific time (PT).
Live Participant Dial In (Toll Free): +1-844-407-9500
Live Participant Dial In (International): +1-862-298-0850
Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/34586
For details on the call, please visit http://www.aemetis.com/investors/conference-calls/
Financial Results for the Three Months Ended March 31, 2020
Revenues during the first quarter of 2020 were $39.5 million, compared to $41.9 million for the first quarter of 2019. North America volume of ethanol sold during the first quarter was 15.7 million gallons compared to 16.2 million gallons in the first quarter of 2019, at an average price of $1.56 per gallon compared to $1.68 per gallon. India's biodiesel price was $786 per metric ton compared to $839 per metric ton, with tons sold decreasing to 3,554 metric tonnes compared to 5,182 tonnes.
Gross loss for the first quarter of 2020 was a $433 thousand loss, compared to a $351 thousand loss during the first quarter of 2019.
Selling, general and administrative expenses decreased from $4.2 million during the first quarter of 2019 to $3.9 million during the first quarter of 2020.
Operating loss decreased to $4.5 million for the first quarter of 2020, compared to operating loss of $4.6 million for the same period in 2019.
Interest expense, excluding accretion of Series A preferred units in the Aemetis Biogas LLC subsidiary, was $6.9 million during the first quarter of 2020 compared to $6.2 million during the first quarter of 2019. Additionally, our Aemetis Biogas initiative recognized $960 thousand of accretion of the preference payments on its preferred stock during the first quarter of 2020 compared to $449 thousand during the first quarter of 2019.
Net loss increased to $12.1 million for the first quarter of 2020, compared to net loss of $10.7 million for the first quarter of 2019.
Cash at the end of the first quarter of 2020 was $303 thousand compared to $656 thousand at the close of the fourth quarter of 2019.
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallons per year ethanol production facility in California's Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallons per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis is building a biogas digester, pipeline and gas cleanup project to convert dairy waste gas into renewable natural gas, and is developing a plant to convert waste orchard wood into cellulosic ethanol. Aemetis holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
NON-GAAP FINANCIAL INFORMATION
We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) attributable to Aemetis, Inc. plus (to the extent deducted in calculating such net income) interest expense, loss on extinguishment, income tax expense, intangible and other amortization expense, accretion expense, depreciation expense and share-based compensation expense.
Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.
Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, expectations for growth in India, the impact that the development of the Dairy Biomethane Digester project and the Cellulosic Ethanol Biorefinery project will have on our business, expected margins at the Cellulosic Ethanol Biorefinery project under development, expectations for uses of EB-5 funding and expectations for receipt of additional EB-5 funding. Words or phrases such as "anticipates," "may," "will," "should," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "showing signs," "targets," "will likely result," "will continue" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2019, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.
External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com
Company Investor Relations/
Media Contact:
Todd Waltz
(408) 213-0940
investors@aemetis.com
(Tables follow)
AEMETIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(unaudited, in thousands except per share data)
| Three months ended | ||||||||
| March 31, 2020 | March 31, 2019 | |||||||
Revenues | $ | 39,480 | $ | 41,888 | ||||
Cost of goods sold | 39,913 | 42,239 | ||||||
Gross loss | (433 | ) | (351 | ) | ||||
Research and development expenses | 117 | 33 | ||||||
Selling, general and administrative expenses | 3,936 | 4,241 | ||||||
Operating loss | (4,486 | ) | (4,625 | ) | ||||
Other expense/(income): | ||||||||
Interest expense | 5,586 | 4,986 | ||||||
Amortization expense | 1,290 | 1,223 | ||||||
Accretion of Series A preferred units | 960 | 449 | ||||||
Other expense | (63 | ) | (623 | ) | ||||
Loss before income taxes | (12,259 | ) | (10,660 | ) | ||||
Income tax expense | (207 | ) | 7 | |||||
Net loss | $ | (12,052 | ) | $ | (10,667 | ) | ||
Non-controlling interest | - | (938 | ) | |||||
Net loss attributable to Aemetis, Inc. | $ | (12,052 | ) | $ | (9,729 | ) | ||
Net loss per common share | ||||||||
Basic | $ | (0.58 | ) | $ | (0.48 | ) | ||
Diluted | $ | (0.58 | ) | $ | (0.48 | ) | ||
Weighted average shares outstanding | ||||||||
Basic | 20,651 | 20,367 | ||||||
Diluted | 20,651 | 20,367 | ||||||
AEMETIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(unaudited, in thousands)
| March 31, 2020 | December 31, 2019 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 303 | $ | 656 | ||||
Accounts receivable | 1,584 | 2,036 | ||||||
Inventories | 5,246 | 6,518 | ||||||
Prepaid and other current assets | 2,720 | 3,366 | ||||||
Total current assets | 9,853 | 12,576 | ||||||
Property, plant and equipment, net | 90,628 | 84,226 | ||||||
Other assets | 3,334 | 3,094 | ||||||
Total assets | $ | 103,815 | $ | 99,896 | ||||
Liabilities and stockholders' deficit | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 16,904 | $ | 15,968 | ||||
Current portion of long-term debt | 6,036 | 5,792 | ||||||
Short term borrowings | 17,327 | 16,948 | ||||||
Mandatorily redeemable Series B stock | 3,175 | 3,149 | ||||||
Accrued property taxes and other liabilities | 17,513 | 15,962 | ||||||
Total current liabilities | 60,955 | 57,819 | ||||||
Total long term liabilities | 209,549 | 196,449 | ||||||
Total stockholders' deficit: | ||||||||
Series B convertible preferred stock | 1 | 1 | ||||||
Common stock | 21 | 21 | ||||||
Additional paid-in capital | 87,255 | 86,852 | ||||||
Accumulated deficit | (249,473 | ) | (237,421 | ) | ||||
Accumulated other comprehensive loss | (4,493 | ) | (3,825 | ) | ||||
Total stockholders' deficit | (166,689 | ) | (154,372 | ) | ||||
Total liabilities and stockholders' deficit | $ | 103,815 | $ | 99,896 | ||||
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
(unaudited, in thousands)
| Three months ended | ||||||||
| March 31, | ||||||||
| 2020 | 2019 | |||||||
Net loss attributable to Aemetis, Inc. | $ | (12,052 | ) | $ | (9,729 | ) | ||
Adjustments: | ||||||||
Interest expense | 6,876 | 5,214 | ||||||
Depreciation expense | 1,090 | 1,138 | ||||||
Accretion of Series A preferred units | 960 | 449 | ||||||
Share-based compensation | 310 | 290 | ||||||
Intangibles and other amortization expense | 12 | 12 | ||||||
Income tax expense/(benefit) | (215 | ) | 7 | |||||
Total adjustments | 9,033 | 7,110 | ||||||
Adjusted EBITDA | $ | (3,019 | ) | $ | (2,619 | ) | ||
PRODUCTION AND PRICE PERFORMANCE
(unaudited)
| Three months ended March 31, | ||||||||
| 2020 | 2019 | |||||||
Ethanol | ||||||||
Gallons sold (in millions) | 15.7 | 16.2 | ||||||
Average sales price/gallon | $ | 1.56 | $ | 1.68 | ||||
Percent of nameplate capacity | 114 | % | 118 | % | ||||
WDG | ||||||||
Tons sold (in thousands) | 107.0 | 106.9 | ||||||
Average sales price/ton | $ | 78 | $ | 80 | ||||
Delivered Cost of Corn | ||||||||
Bushels ground (in millions) | 5.7 | 5.6 | ||||||
Average delivered cost / bushel | $ | 5.17 | $ | 5.20 | ||||
Biodiesel | ||||||||
Metric tons sold (in thousands) | 3.6 | 5.2 | ||||||
Average Sales Price/Metric ton | $ | 786 | $ | 839 | ||||
Percent of nameplate capacity | 9 | % | 13 | % | ||||
Refined glycerin | ||||||||
Metric tons sold (in thousands) | 0.1 | 1.4 | ||||||
Average Sales Price/Metric ton | $ | 619 | $ | 644 | ||||
SOURCE: Aemetis, Inc.
https://www.accesswire.com/589785/Aemetis-Inc-Reports-First-Quarter-2020-Financial-Results
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
